Breaking News

  • 1 hour ago

  • Pharma Now Editorial Team

OrganaBio Acquires Excellos Assets to Expand Cell Therapy CDMO Capacity in San Diego
Breaking News

More News

SN Bioscience Achieves First Patient Dosing in Global Phase I SCLC Trial for SNB-101

SN Bioscience Achieves First Patient Dosing in Global Phase I SCLC Tri...

Pharma Now Editorial Team

Pfizer Appoints Ashish Doshi as Director at IITM Research Park Chennai Facility

Pfizer Appoints Ashish Doshi as Director at IITM Research Park Chennai...

Pharma Now Editorial Team

Bayer's NUBEQA Combination Achieves 71% Risk Reduction in Phase II Metastatic Prostate Cancer Trial

Bayer's NUBEQA Combination Achieves 71% Risk Reduction in Phase II Met...

Pharma Now Editorial Team

Strand Life Sciences Launches Olink Explore HT Proteomics Platform for Biomarker Discovery

Strand Life Sciences Launches Olink Explore HT Proteomics Platform for...

Pharma Now Editorial Team

Ad
Advertisement

Interviews & Opinions

Article

From ‘Why Reject?’ to ‘How Release?’: Deepak Kasbi on the Cultural Shift in Pharma Quality

One question flipped pharma quality culture. Kasbi on why India still struggles with sustained compliance and what QA policing gets wrong.

FT - Mr. Deepak Kasbi

Read More

Article
Five Pillars Of Leadership That Built A Pharma Veteran: Shyam Khante’s 45-Year Pharma Journey

FT - Mr. Shyam Khante

Article
“Quality is Driven by Science” – Leadership Lessons from Zydus President Vikram Shukla

FT - Mr. Vikram Shukla

Article
Mr. Patrick Nieuwenhuizen on Contamination Control, AI, and Leadership

FT - Mr. Patrick Nieuwenhuizen

Ad
Advertisement
Ad